Current Projects & Research Grants

  • Target-specific gastro-intestinal delivery of nano-nutraceuticals and nano-modulating systems for reducing absorption of unwanted substances – A sustainable approach (NTU-Harvard/2017)
  • Responsive nasogastric tubes for confident intubation (MOE POC/2017)
  • Microbial-modifying molecules that enhance wastewater remediation (MOE/2016)
  • Dual‐chemotherapeutic drug delivery systems – pharmacokinetics and pharmacodynamics validation (SPARK/2016)
  • Controlled release polypharmacy system for parkinson's disease management (NTU-NHG/ 2014)
  • Bringing novel biomarkers and technologies closer to clinical application (NHG/2013)
  • Understanding the social, environmental and health impact of nanomaterials (NTU/2013)
  • Developing paclitaxel-loaded poly(lactic-co-glycolic acid) (PLGA) particles as a treatment modality in breast cancer (NMRC/2013)
  • Artificial molecular wires/nanowires for enhancing bioelectronic performance (MOE-Tier 2/2013
  • Development of novel remote bioelectrochemical detectors (BED) for sustainable water infrastructure (SEO/2013)
  • Enhancing microbial redox metabolism for reductive transformations using TETMs (SCELSE/2012
  • Conceptual design of the gastric band (SPRING/2011)
  • TiO2 nanomaterials cause endothelial cell leakiness (MOE-Tier 1/2011)
  • Development of sustained release ganciclovir implant for treatment of CMV retinitis in HIV-AIDS patients (NTU-NHG/2011)
  • Drug-Eluting Balloons (DEB) – Controlled delivery through nanoparticulate coating (NTU-NITHM/2011
  • Drug loaded microparticles encapsulated into bioadhesive films, locally delivered by angioplasty balloons (NRF POC/2011)
  • Drug-releasing bioactive materials and adipose stem cells as autologous scaffolds for bone tissue engineering (A*STAR/2011)
  • Effect of topical application of encapsulated PPARbeta/delta agonist GW501516 microparticles, with two release kinetics, on cutaneous wound healing in diabetic mice – a preclinical animal study (NMRC/2011
  • Bone-targeting nanomedicine for treating osteomyelitis (NMRC/2009)
  • Biodegradable cardiovascular implants: drug-eluting balloons (NRF/2008)
  • Stealth hydroxyapatite nanoparticle for targeted delivery and bioimaging (MOE-Tier1/2007)